50276-98-7 Usage
Uses
Used in Pharmaceutical Research:
3,4-Dihydro-1-oxo-1H-2-benzopyran-5-carbaldehyde is used as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Chemical Research:
In the field of chemical research, 3,4-Dihydro-1-oxo-1H-2-benzopyran-5-carbaldehyde serves as a valuable compound for studying the properties and reactions of benzopyran derivatives. Its reactivity and stability contribute to a better understanding of the chemical behavior of similar compounds.
Used in Industrial Product Development:
3,4-Dihydro-1-oxo-1H-2-benzopyran-5-carbaldehyde may have potential applications in the development of various industrial products, such as dyes, pigments, and other specialty chemicals. Its unique properties can contribute to the creation of innovative and high-performance materials.
Used in Drug Synthesis:
3,4-Dihydro-1-oxo-1H-2-benzopyran-5-carbaldehyde is used as a building block in the synthesis of new drug candidates. Its presence in the molecular structure can impart specific biological activities, making it a valuable component in the development of novel therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 50276-98-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,0,2,7 and 6 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 50276-98:
(7*5)+(6*0)+(5*2)+(4*7)+(3*6)+(2*9)+(1*8)=117
117 % 10 = 7
So 50276-98-7 is a valid CAS Registry Number.
InChI:InChI=1/C10H8O3/c11-6-7-2-1-3-9-8(7)4-5-13-10(9)12/h1-3,6H,4-5H2
50276-98-7Relevant academic research and scientific papers
Jun, Chang,Xue-Ming, Zhao,Chang-Xiao, Liu,Tie-Jun, Zhang
, p. 22 - 25 (2008)
The in vitro metabolism of swertiamarin was carried out in preparative scale using the fungus Aspergillus niger and the metabolites were isolated by semi-preparative HPLC combined with liquid-liquid extraction. Two metabolites, erythrocentaurin and one new compound were obtained and identified by 1H, 13C and 2D NMR and high resolution MS. The anti-inflammatory activity of the novel metabolite was tested and compared with that of swertiamarin in a mice model.
Zou, Ya-Dan,Ma, Xiao-Xia,Du, Sheng-Nan,Qi, Ping-Xing,He, Fang-Yan,Yang, Zhu-Ya,Tan, Wen-Hong,Khan, Afsar,Zhou, Zhi-Hong,Liu, Lu
, (2021)
Swertia mileensis, known as Qing-Ye-Dan (QYD), has been documented in Chinese Pharmacopoeia to cure hepatitis. Interestingly, its announced main active component, swertiamarin, could not be detected in the decoction, which indicated that the efficacy of QYD might be attributed to heat-transformed products of swertiamarin (HTPS). Further investigation on HTPS led to the isolation of sweritranslactone D (1), a novel secoiridoid dimer possessing a tetracyclic lactone skeleton, with better hepatoprotective activity than N-acetyl-L-cysteine in vitro.
